News related to Rituxan (Rituximab) and/or conditions it is approved for
Global long-term study: Rituxan shows consistent safety profile over 11 years
Source: Arthritis / Rheumatology News From Medical News Today [2015.08.20]
The online edition of The Journal of Rheumatology has published a study on the long-term safety of Rituxan which found that it has a consistent safety profile over time and through multiple courses...
NICE recommends Zydelig (idelalisib) for the treatment of chronic lymphocytic leukaemia
Source: Blood / Hematology News From Medical News Today [2015.09.28]
Gilead Sciences' Zydelig® (idelalisib) has been recommended by the National Institute for Health and Care Excellence (NICE) as a treatment option in combination with rituximab for adults with...
Source: MedicineNet Biological Therapy Specialty [2015.04.01]
Title: Non-Hodgkin's Lymphoma
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 4/1/2015 12:00:00 AM